Cite
Lee JH, Chung KS, Lee HH, et al. Improved tumor-suppressive effect of OZ-001 combined with cisplatin mediated by mTOR/p70S6K and STAT3 inactivation in A549 human lung cancer cells. Biomed Pharmacother. 2021;142:111961doi: 10.1016/j.biopha.2021.111961.
Lee, J. H., Chung, K. S., Lee, H. H., Ko, D., Kang, M., Yoo, H., Ahn, J., Lee, J. Y., & Lee, K. T. (2021). Improved tumor-suppressive effect of OZ-001 combined with cisplatin mediated by mTOR/p70S6K and STAT3 inactivation in A549 human lung cancer cells. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 142111961. https://doi.org/10.1016/j.biopha.2021.111961
Lee, Jeong-Hun, et al. "Improved tumor-suppressive effect of OZ-001 combined with cisplatin mediated by mTOR/p70S6K and STAT3 inactivation in A549 human lung cancer cells." Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie vol. 142 (2021): 111961. doi: https://doi.org/10.1016/j.biopha.2021.111961
Lee JH, Chung KS, Lee HH, Ko D, Kang M, Yoo H, Ahn J, Lee JY, Lee KT. Improved tumor-suppressive effect of OZ-001 combined with cisplatin mediated by mTOR/p70S6K and STAT3 inactivation in A549 human lung cancer cells. Biomed Pharmacother. 2021 Oct;142:111961. doi: 10.1016/j.biopha.2021.111961. Epub 2021 Jul 28. PMID: 34329824.
Copy
Download .nbib